Spatial proteomics of Onchocerca volvulus with pleomorphic neoplasms shows local and systemic dysregulation of

Lucia S Di Maggio1, Kerstin Fischer1, Bruce A Rosa1

  • 1Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Insights

Mass drug administration with ivermectin targets river blindness (onchocerciasis). This study identified proteins in neoplasms (PN) of the parasite Onchocerca volvulus, potentially explaining ivermectin

Area of Science:

  • Parasitology
  • Molecular Biology
  • Drug Discovery

Background:

  • Onchocerca volvulus causes river blindness, targeted for elimination via ivermectin.
  • A subset of worms develops pleomorphic neoplasms (PN), linked to ivermectin treatment frequency.
  • Understanding PN protein expression may reveal ivermectin's macrofilaricidal mechanisms.

Purpose of the Study:

  • To identify proteins within PN and associated with their development.
  • To compare protein expression in PN tissues versus normal tissues.
  • To investigate systemic protein dysregulation in ivermectin-treated worms.

Main Methods:

  • Histological detection of PN in O. volvulus females from a clinical trial.
  • Laser capture microdissection of neoplasm and normal tissues.
  • High-sensitivity mass spectrometry for protein identification and quantification.

Main Results:

  • 1,577 proteins identified in PN; significantly fewer proteins detected in other tissues of PN-affected worms compared to controls.
  • Uterus of one PN worm showed altered protein count (601) versus healthy controls (1,710).
  • Calcium-binding protein OvDig-1 confirmed in PN via immunolocalization.

Conclusions:

  • Proteins potentially linked to PN development were identified.
  • Systemic dysregulation of protein expression may contribute to worm mortality.
  • Findings offer insights into ivermectin's effects on O. volvulus.